Injective Bets on Built-In Market Rails as Assets Move Onchain

Injective, a layer-1 blockchain founded in 2018 by Eric Chen and Albert Chon, builds core financial market infrastructure directly into its base layer rather than leaving it to application developers. In August 2026, Injective Institutional Services became an SEC-registered transfer agent, giving the network a recognized role in maintaining official securities ownership records. Writing for the "Crypto for Advisors" newsletter from Canary Capital, Josh Olszewicz framed the chain as a case study in whether specialized infrastructure can compete with general-purpose networks as traditional assets move onchain.

What does the base layer actually provide?

On networks such as Ethereum and Solana, exchanges typically deploy their own contracts for order handling and settlement, which splits liquidity across applications. Injective takes the opposite approach, providing these functions at the protocol level: a native onchain order book — the market structure used by traditional exchanges — plus shared modules for derivatives, oracles and token issuance.

The chain runs proof-of-stake consensus built on CometBFT (Byzantine Fault Tolerant), delivering near-instant finality, block times of roughly 620 milliseconds and average fees around 0.17 cents. For comparison, that fee level sits well below typical Ethereum mainnet costs.

Its Multi-Virtual-Machine (MultiVM) architecture lets native modules, WebAssembly contracts and, since November 2025, a native Ethereum Virtual Machine run over shared state. That means Ethereum developers can bring existing code to Injective without rebuilding it. Interoperability links run through Inter-Blockchain Communication (IBC) to Cosmos chains, plus connections to Ethereum and Solana, positioning the network as connective tissue for liquidity scattered across ecosystems.

Where are the real-world assets?

Injective began as a decentralized derivatives venue and has grown into a financial layer-1 supporting spot and derivatives markets, lending, stablecoins and tokenized real-world assets. Injective Mint, launched in July 2026, lets issuers enforce holder restrictions, jurisdictional controls and redemption permissions on tokenized products.

Early use cases span several corners of finance:

• Pineapple Financial has moved more than $1 billion in mortgage records onchain.
• POSCO International and LG CNS are piloting tokenized trade receivables.
• Through Libre, Injective offers access to tokenized funds associated with BlackRock, Hamilton Lane and Nomura's Laser Digital, including private credit.

Tokenized assets that trade and settle on Injective generate fees, and that activity links to $INJ, the network's native token, which is subject to recurring token burns.

Why should advisors watch the infrastructure?

In the newsletter's "Ask an Expert" segment, Kieran Mitha argued that advisors should watch the infrastructure taking shape on chains like Injective, whatever they think of the token itself. The operational question for wealth professionals is whether protocol-level market plumbing — transfer-agent status, compliance controls and cross-chain settlement — reduces the friction of moving securities onchain.

The SEC transfer-agent registration and the November 2025 EVM rollout mark Injective's clearest steps toward institutional relevance. Whether tokenized volume follows depends on issuers adopting rails like Injective Mint over the next market cycle.